NCT04175912

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2020-03-16Est. Completion: 2023-11-27

Enrollment target: 40 participants

Locations

Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
Anchorage Oncology Centre, Anchorage, Alaska, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Kingman Regional Medical Center, Kingman, Arizona, United States
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States
PCR Oncology, Arroyo Grande, California, United States
Sutter Auburn Faith Hospital, Auburn, California, United States
Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States

Intrahepatic Cholangiocarcinoma (Icc)

This is a phase III, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety o…

Guangzhou, ChinaEst. completion Jan 2030

Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm

Background: Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.